Strusi, G.; Suelzu, C.M.; Weldon, S.; Giffin, J.; Münsterberg, A.E.; Bao, Y.
Combination of Phenethyl Isothiocyanate and Dasatinib Inhibits Hepatocellular Carcinoma Metastatic Potential through FAK/STAT3/Cadherin Signalling and Reduction of VEGF Secretion. Pharmaceutics 2023, 15, 2390.
https://doi.org/10.3390/pharmaceutics15102390
AMA Style
Strusi G, Suelzu CM, Weldon S, Giffin J, Münsterberg AE, Bao Y.
Combination of Phenethyl Isothiocyanate and Dasatinib Inhibits Hepatocellular Carcinoma Metastatic Potential through FAK/STAT3/Cadherin Signalling and Reduction of VEGF Secretion. Pharmaceutics. 2023; 15(10):2390.
https://doi.org/10.3390/pharmaceutics15102390
Chicago/Turabian Style
Strusi, Gabriele, Caterina M. Suelzu, Shannon Weldon, Jennifer Giffin, Andrea E. Münsterberg, and Yongping Bao.
2023. "Combination of Phenethyl Isothiocyanate and Dasatinib Inhibits Hepatocellular Carcinoma Metastatic Potential through FAK/STAT3/Cadherin Signalling and Reduction of VEGF Secretion" Pharmaceutics 15, no. 10: 2390.
https://doi.org/10.3390/pharmaceutics15102390
APA Style
Strusi, G., Suelzu, C. M., Weldon, S., Giffin, J., Münsterberg, A. E., & Bao, Y.
(2023). Combination of Phenethyl Isothiocyanate and Dasatinib Inhibits Hepatocellular Carcinoma Metastatic Potential through FAK/STAT3/Cadherin Signalling and Reduction of VEGF Secretion. Pharmaceutics, 15(10), 2390.
https://doi.org/10.3390/pharmaceutics15102390
